1
|
Poletti de Chaurand V, Scandella G, Zicoia M, Arienti F, Fernicola F, Lanteri L, Guglielmi D, Carli A, Vasarri MV, Iozzi L, Cavallero A, Malandrin SMI, Locatelli A, Ventura ML, Sinelli M, Ornaghi S. Useful Clinical Criteria for Identifying Neonates with Congenital Cytomegalovirus Infection at Birth in the Context of an Expanded Targeted Screening Program. Viruses 2024; 16:1138. [PMID: 39066300 PMCID: PMC11281348 DOI: 10.3390/v16071138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2024] [Revised: 07/07/2024] [Accepted: 07/13/2024] [Indexed: 07/28/2024] Open
Abstract
Cytomegalovirus (CMV) is the leading infectious cause of brain defects and neurological dysfunctions, including sensorineural hearing loss (SNHL). Targeted screening in neonates failing the hearing screen is currently recommended in Italy according to national guidelines. However, SNHL may not be present at birth; also, congenital CMV (cCMV) may manifest with subtle signs other than SNHL. Therefore, the inclusion of additional criteria for cCMV screening appears clinically valuable. Starting January 2021, we have implemented expanded targeted cCMV screening at our center, with testing in case of maternal CMV infection during pregnancy, inadequate antenatal care, maternal HIV infection or immunosuppression, birthweight and/or head circumference < 10th centile, failed hearing screen, and prematurity. During the first three years of use of this program (2021-2023), 940 (12.3%) of 7651 live-born infants were tested. The most common indication was birthweight < 10th centile (n = 633, 67.3%). Eleven neonates were diagnosed as congenitally infected, for a prevalence of 1.17% (95%CI 0.48-1.86) on tested neonates and of 0.14% (95%CI 0.06-0.23) on live-born infants. None of the cCMV-infected newborns had a failed hearing screen as a testing indication. Implementation of an expanded cCMV screening program appears feasible and of clinical value.
Collapse
Affiliation(s)
- Valeria Poletti de Chaurand
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Gaia Scandella
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Marianna Zicoia
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
- Neonatal Intensive Care Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (L.I.); (M.L.V.); (M.S.)
| | - Francesca Arienti
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Federica Fernicola
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Laura Lanteri
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Diletta Guglielmi
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Anna Carli
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
| | - Maria Viola Vasarri
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Lucia Iozzi
- Neonatal Intensive Care Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (L.I.); (M.L.V.); (M.S.)
| | - Annalisa Cavallero
- Microbiology Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (A.C.); (S.M.I.M.)
| | | | - Anna Locatelli
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| | - Maria Luisa Ventura
- Neonatal Intensive Care Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (L.I.); (M.L.V.); (M.S.)
| | - Mariateresa Sinelli
- Neonatal Intensive Care Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (L.I.); (M.L.V.); (M.S.)
| | - Sara Ornaghi
- Obstetric Unit, Foundation IRCCS San Gerardo dei Tintori, 20900 Monza, MB, Italy; (V.P.d.C.); (G.S.); (F.A.); (F.F.); (L.L.); (D.G.); (A.C.); (M.V.V.); (A.L.)
- School of Medicine and Surgery, University of Milan-Bicocca, Via Cadore 48, 20900 Monza, MB, Italy;
| |
Collapse
|
2
|
Zhang Y, Egashira T, Egashira M, Ogiwara S, Tomino H, Shichijo A, Mizukami T, Ogata T, Moriuchi H, Takayanagi T. Expanded targeted screening for congenital cytomegalovirus infection. Congenit Anom (Kyoto) 2023; 63:79-82. [PMID: 36946004 DOI: 10.1111/cga.12512] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/29/2022] [Revised: 01/19/2023] [Accepted: 02/26/2023] [Indexed: 03/23/2023]
Abstract
An early diagnosis and intervention for congenital cytomegalovirus infection can reduce long-term disability; however, the introduction of universal neonatal screening has been controversial worldwide. The present study clarified the outcome of a targeted screening protocol for detecting congenital cytomegalovirus infection based on suggestive perinatal conditions. In addition, the positive rate was compared to those from the reported studies and the validity of the targeted screening criteria was discussed. A total of 2121 newborn infants were admitted to our hospital between October 2018 and October 2021. Cytomegalovirus DNA was examined by the isothermal nucleic acid amplification method for urine samples from newborns with any of the following: microcephaly, abnormal ultrasound findings in the brain and visceral organs, repeated failure in neonatal hearing screening, suspicious maternal cytomegalovirus infection during pregnancy, and other abnormal findings suggestive of congenital cytomegalovirus infection. Among 2121 newborns, 102 (4.8%) were subject to the urine cytomegalovirus DNA test based on the abovementioned criteria. Of them, three were cytomegalovirus DNA-positive. According to the protocol, the cytomegalovirus DNA-positive rates were 0.14% among the total enrollment of 2121 newborns and 2.9% (3/102) among the targeted newborns. This protocol may overlook congenital cytomegalovirus infection that is asymptomatic or exhibits inapparent clinical manifestations only at birth; however, it is feasible and helps lead to the diagnosis of congenital cytomegalovirus infection that may otherwise be overlooked.
Collapse
MESH Headings
- Humans
- Infant, Newborn
- Cytomegalovirus/genetics
- Cytomegalovirus/isolation & purification
- Cytomegalovirus/physiology
- Cytomegalovirus Infections/diagnosis
- Cytomegalovirus Infections/pathology
- Cytomegalovirus Infections/urine
- Cytomegalovirus Infections/virology
- Infant, Newborn, Diseases/diagnosis
- Infant, Newborn, Diseases/pathology
- Infant, Newborn, Diseases/urine
- Infant, Newborn, Diseases/virology
- Neonatal Screening
- Female
- Pregnancy
- DNA, Viral/genetics
Collapse
Affiliation(s)
- Yumeng Zhang
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
- Department of Pediatrics, Faculty of Medicine, Saga University, 5-1-1 Nabeshima, Saga, 849-8501, Japan
| | - Tomoko Egashira
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| | - Masakazu Egashira
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| | - Shun Ogiwara
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| | - Hiroyuki Tomino
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| | - Akinori Shichijo
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| | - Tomoko Mizukami
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| | - Tsutomu Ogata
- Department of Pediatrics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan
| | - Hiroyuki Moriuchi
- Department of Pediatrics, Graduate School of Biomedical Sciences, Nagasaki University, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan
| | - Toshimitsu Takayanagi
- Department of Pediatrics, National Hospital Organization Saga National Hospital, 1-20-1 Hinode, Saga, 849-8577, Japan
| |
Collapse
|
3
|
Smits I, Hoftiezer L, van Dillen J, Hogeveen M. Neonatal hypoglycaemia and body proportionality in small for gestational age newborns: a retrospective cohort study. Eur J Pediatr 2022; 181:3655-3662. [PMID: 35980543 PMCID: PMC9508048 DOI: 10.1007/s00431-022-04592-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Revised: 07/28/2022] [Accepted: 08/06/2022] [Indexed: 11/28/2022]
Abstract
Small for gestational age (SGA) newborns are at risk of developing neonatal hypoglycaemia. SGA newborns comprise a heterogeneous group including both constitutionally small and pathologically growth restricted newborns. The process of fetal growth restriction may result in brain sparing at the expense of the rest of the body, resulting in disproportionally small newborns. The aim of this study was to discover whether body proportionality influences the risk of developing neonatal hypoglycaemia in SGA newborns. A retrospective cohort study was performed in 402 newborns who were SGA without additional risk factors for hypoglycaemia. Body proportionality was classified in two ways: (1) using symmetric (sSGA) or asymmetric (aSGA), defined as head circumference (HC) below or above the 10th percentile, respectively; (2) using cephalization index (HC/birth weight), standardized for gestational age. Hypoglycaemia was observed in 50% of aSGA and 40.9% of sSGA newborns (P-value 0.12). Standardized CI in newborns with hypoglycaemia was higher compared to newborns without hypoglycaemia (median 1.27 (1.21-1.35) versus 1.24 (1.20-1.29); (P 0.002)). Multivariate logistic regression analyses showed both CI and standardized CI to be associated with the occurrence of hypoglycaemia (OR 1.48 (1.24-1.77) and OR 1.44 (1.13-1.83), respectively). The majority of hypoglycaemic events (96.1%) occurred in the first 6 h after birth. Conclusion: Body proportionality might be of influence, depending on the classification used. Larger prospective studies with a clear consensus definition of body proportionality are needed. What is Known: • Neonatal hypoglycaemia is an important complication in newborns. • Small for gestational age (SGA) newborns are more vulnerable to hypoglycaemia. What is New: • Higher incidence of hypoglycaemia was not observed in asymmetric SGA compared to symmetric SGA, but standardized cephalization index was associated with increased likelihood of hypoglycaemia. • Consensus-based definitions of body proportionality in newborns are needed.
Collapse
Affiliation(s)
- Ilke Smits
- Department of Obstetrics and Gynaecology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
| | - Liset Hoftiezer
- Division of Neonatology, Department of Paediatrics, Amalia Children’s Hospital, Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
| | - Jeroen van Dillen
- Department of Obstetrics and Gynaecology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands
| | - Marije Hogeveen
- Division of Neonatology, Department of Paediatrics, Amalia Children's Hospital, Radboud Institute for Health Sciences, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
| |
Collapse
|